Rudolf Andrýs

667 total citations
49 papers, 443 citations indexed

About

Rudolf Andrýs is a scholar working on Pharmacology, Plant Science and Molecular Biology. According to data from OpenAlex, Rudolf Andrýs has authored 49 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 17 papers in Plant Science and 15 papers in Molecular Biology. Recurrent topics in Rudolf Andrýs's work include Cholinesterase and Neurodegenerative Diseases (23 papers), Pesticide Exposure and Toxicity (14 papers) and Environmental Toxicology and Ecotoxicology (7 papers). Rudolf Andrýs is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (23 papers), Pesticide Exposure and Toxicity (14 papers) and Environmental Toxicology and Ecotoxicology (7 papers). Rudolf Andrýs collaborates with scholars based in Czechia, Serbia and Spain. Rudolf Andrýs's co-authors include Kamil Musílek, David Maliňák, Kamil Kuča, José Marco‐Contelles, Ondřej Soukup, Andrea Angeli, Robert Czarnomysy, Tomasz Plech, Barbara Kaproń and Claudiu T. Supuran and has published in prestigious journals such as Analytical Chemistry, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Rudolf Andrýs

43 papers receiving 433 citations

Peers

Rudolf Andrýs
José Dias France
Irina V. Zueva Russia
Andreas Hörnberg Sweden
Özden Tacal Türkiye
John M. Clancy Ireland
Alessandro Pesaresi Italy
Leonardo Brunetti Italy
Efraim Shek United States
Daniela Valeria Miniero Italy
Tuba Tüylü Küçükkılınç Türkiye
José Dias France
Rudolf Andrýs
Citations per year, relative to Rudolf Andrýs Rudolf Andrýs (= 1×) peers José Dias

Countries citing papers authored by Rudolf Andrýs

Since Specialization
Citations

This map shows the geographic impact of Rudolf Andrýs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Andrýs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Andrýs more than expected).

Fields of papers citing papers by Rudolf Andrýs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rudolf Andrýs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Andrýs. The network helps show where Rudolf Andrýs may publish in the future.

Co-authorship network of co-authors of Rudolf Andrýs

This figure shows the co-authorship network connecting the top 25 collaborators of Rudolf Andrýs. A scholar is included among the top collaborators of Rudolf Andrýs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudolf Andrýs. Rudolf Andrýs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrýs, Rudolf, et al.. (2026). Derivatization agents for LC-MS analysis of amino acids: effects of core structure and functional groups. Analytical and Bioanalytical Chemistry.
2.
3.
Andrýs, Rudolf, et al.. (2025). Chitosan-based film-forming systems with cannabidiol: a novel topical strategy for antimicrobial therapy. International Journal of Pharmaceutics. 682. 125940–125940. 1 indexed citations
4.
Schmidt, Monika, Ondřej Benek, Ivo Fabrik, et al.. (2025). New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 170–170.
5.
Andrýs, Rudolf, et al.. (2024). Halogenated monopyridinium oximes are less effective in reactivation of phosphylated cholinesterases than bisquaternary oximes. Bioorganic Chemistry. 153. 107904–107904. 1 indexed citations
6.
Andrýs, Rudolf, et al.. (2024). Towards cost-effective drug discovery: Reusable immobilized enzymes for neurological disease research. Talanta. 276. 126263–126263. 2 indexed citations
7.
Andrýs, Rudolf, et al.. (2024). Formulation study of PLGA in situ films for topical delivery of salicylates. European Journal of Pharmaceutics and Biopharmaceutics. 199. 114282–114282.
8.
Svobodová, Barbora, Dawid Panek, Rudolf Andrýs, et al.. (2023). Structure-Guided Design of N-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 24(11). 9124–9124. 4 indexed citations
9.
Maliňák, David, Rudolf Andrýs, Tomáš Mikýsek, et al.. (2022). Optimization of gradient reversed phase high performance liquid chromatography analysis of acetaminophen oxidation metabolites using linear and non-linear retention model. Journal of Chromatography A. 1669. 462956–462956. 18 indexed citations
10.
Karasová, Jana Žďárová, Jiřı́ Kassa, Vendula Hepnarová, et al.. (2022). Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K870. Food and Chemical Toxicology. 167. 113236–113236. 2 indexed citations
11.
12.
Zorbaz, Tamara, David Maliňák, Suzana Žunec, et al.. (2022). Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents. European Journal of Medicinal Chemistry. 238. 114377–114377. 11 indexed citations
13.
Chrienová, Žofia, Eugenie Nepovimová, Rudolf Andrýs, et al.. (2022). Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2605–2620. 9 indexed citations
14.
Andrýs, Rudolf, Jakub Jończyk, David Maliňák, et al.. (2021). Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 437–449. 3 indexed citations
15.
Maliňák, David, Jan Čapek, Rudolf Andrýs, et al.. (2021). Effects of Charged Oxime Reactivators on the HK-2 Cell Line in Renal Toxicity Screening. Chemical Research in Toxicology. 34(3). 699–703. 11 indexed citations
16.
Mezeiová, Eva, Jana Janočková, Rudolf Andrýs, et al.. (2020). 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 211. 113112–113112. 25 indexed citations
17.
Górecki, Lukáš, Rudolf Andrýs, Monika Schmidt, et al.. (2019). Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible Inhibitors. ACS Medicinal Chemistry Letters. 11(1). 65–71. 13 indexed citations
18.
19.
Andrýs, Rudolf, Marc Meier, Gabriele Möller, et al.. (2018). Initial characterization of human DHRS1 (SDR19C1), a member of the short-chain dehydrogenase/reductase superfamily. The Journal of Steroid Biochemistry and Molecular Biology. 185. 80–89. 5 indexed citations
20.
Andrýs, Rudolf, et al.. (2015). Carbonyl-reducing enzymes as targets of a drug-immobilised affinity carrier. Chemico-Biological Interactions. 234. 169–177. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Dias Breakdown of academic impact, for papers by Irina V. Zueva Breakdown of academic impact, for papers by Andreas Hörnberg Breakdown of academic impact, for papers by Özden Tacal Breakdown of academic impact, for papers by John M. Clancy Breakdown of academic impact, for papers by Alessandro Pesaresi Breakdown of academic impact, for papers by Leonardo Brunetti Breakdown of academic impact, for papers by Efraim Shek Breakdown of academic impact, for papers by Daniela Valeria Miniero Breakdown of academic impact, for papers by Tuba Tüylü Küçükkılınç
Rankless by CCL
2026